MiR-520b inhibited metastasis and proliferation of non-small cell lung cancer by targeting CHAF1A.
CONCLUSIONS: We discovered the inhibitory function of miR-520b in NSCLC by targeting CHAF1A. Moreover, our study revealed that the miR-520b/CHAF1A axis might be a potential therapeutic target for the treatment of NSCLC.
PMID: 30536318 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Epithelial Cancer | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Study